The Cell BriefLongevity
NAD+: The Tiny Helper First Found in Yeast Juice
NAD+ is not a peptide but a helper molecule every cell uses to turn food into energy. Here is its yeast-juice origin story and what studies have found so far.

In 1906, two scientists were studying yeast juice. Yeast are tiny living cells that turn sugar into alcohol and bubbles. The team pushed the juice through a very fine filter and split it in two.
Alone, neither part could turn sugar into alcohol. Mixed back together, the bubbles came back. A tiny helper had slipped through the filter. Today we call it NAD+, and every cell in your body uses it.
What it is
NAD+ is not a peptide. A peptide is a short chain of amino acids, like a short bead bracelet. New to this? Start with what a peptide is.
NAD+ is a coenzyme instead. That is a small helper that enzymes need to do their jobs. Enzymes are the cell's tiny workers, and hundreds of them use NAD+.
Your cells build NAD+ from forms of vitamin B3 in food. They can also make it from tryptophan, an amino acid found in protein. Two of its building blocks have short, well-known names: NR and NMN.

In 1929, studies of how yeast juice breaks down sugar, including this helper, earned a Nobel Prize in Chemistry. NAD+ belongs on a peptide site because it sits at the heart of cell energy and aging research.
What it does in the body
Your cells get energy by slowly breaking down food. NAD+ helps carry that energy to where it is needed.
Think of NAD+ as a honeybee. As food breaks down, it picks up a load of electrons. These are tiny charged specks that hold energy. Once loaded, it gets a new name: NADH.
It flies the load to the mitochondria, the cell's power plants. There it drops off the electrons, which help make the cell's fuel. Then it heads back, empty, for more.

NAD+ has a second job, too. Some proteins use it up as they work. One group helps fix damaged DNA. Another group, called sirtuins, helps keep some genes switched off. Sirtuins need NAD+ to work.
What scientists have found
In cells: Yeast gave scientists another big clue. In 2000, a team put yeast cells on a low-calorie diet. The cells lived much longer.
But the bonus vanished in yeast missing a key sirtuin gene. It also vanished in yeast missing a gene they use to make NAD+. So the longer life seemed to need both.

In animals: In lab worms, flies and rodents, NAD+ levels drop with age. The drop ranges from about 10% to 65%, depending on the organ and the age.
In a 2016 study, mice got NMN, a building block of NAD+, for a full year. They gained less weight with age, even though they ate a bit more. Their bodies handled insulin better, and their eyes and bones held up better. The team saw no obvious harmful effects.
In people: Lower NAD+ also tends to go along with older age in people.
In small trials, healthy volunteers took NR or NMN. Their NAD+ levels rose, and the building blocks appeared safe. Effects on other health measures have been mixed so far.
What about NAD+ itself? In a 2019 pilot study, eight healthy men got NAD+ by a slow drip into a vein. Three more got a salt-water drip instead. For the first two hours, blood NAD+ did not change, as the body cleared it fast. By the end of six hours, it had climbed well above where it started. No side effects were seen during the drip.
Where it stands
NAD+ is not an FDA-approved medicine.
The big question now is whether raising NAD+ can help people stay healthy as they age. Researchers want larger and longer trials in people to find out. That is the exciting next step.
For more on the cell's power plants, meet MOTS-c, a tiny peptide whose recipe hides inside them. Then see SS-31, a lab-made peptide that heads straight for them.
The bottom line
- NAD+ is not a peptide. It is a helper molecule every cell uses, first spotted in yeast juice in 1906.
- Like a honeybee, it carries energy from food to the cell's power plants. Sirtuins need it, too.
- Levels tend to drop with age in animals and people. Its building blocks raised NAD+ in small human trials, and bigger trials are next.
FAQ
Questions people ask
- What is NAD+?
- NAD+ is a coenzyme, a small helper molecule that hundreds of enzymes need. It carries energy from food to the mitochondria, the cell's power plants.
- Is NAD+ FDA approved?
- No. NAD+ is not an FDA-approved medicine. Its building blocks, NR and NMN, have been studied in small trials in healthy volunteers.
- What are the side effects of NAD+?
- In a 2019 pilot study, no side effects were seen in eight men during a slow six-hour drip into a vein. In a small 2026 study of clinic records, all six people given NAD+ drips reported effects such as stomach cramps, nausea and chest pressure, which stopped when each drip ended.
- What is the difference between NAD+, NR and NMN?
- NAD+ is the working helper molecule itself. NR and NMN are smaller building blocks that cells turn into NAD+, and in small trials in healthy volunteers they raised NAD+ levels.
Sources8
- Award ceremony speech: The Nobel Prize in Chemistry 1929 · NobelPrize.org (Nobel Prize Outreach), 1929
- NAD+ Metabolism and Regulation: Lessons From Yeast · Biomolecules, 2020 · DOI 10.3390/biom10020330
- NAD+ metabolism and its roles in cellular processes during ageing · Nature Reviews Molecular Cell Biology, 2021 · DOI 10.1038/s41580-020-00313-x
- Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae · Science, 2000 · DOI 10.1126/science.289.5487.2126
- Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice · Cell Metabolism, 2016 · DOI 10.1016/j.cmet.2016.09.013
- A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+ · Frontiers in Aging Neuroscience, 2019 · DOI 10.3389/fnagi.2019.00257
- Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting · Frontiers in Aging, 2026 · DOI 10.3389/fragi.2026.1652582
- Drugs@FDA: FDA-Approved Drugs · U.S. Food and Drug Administration, 2026
Education only. Not medical advice. The Cell Brief summarises published research for general education. It is not medical advice, and nothing here is a recommendation to use any compound.
Which peptide family should you explore first?
Answer a few questions about your everyday life. Get your peptide family, the briefs to read first, and the full list in your inbox.
Take the quiz

